We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
Hims & Hers Health, Inc.
Health Care · Health Care Technology
Structural: vertically integrated DTC telehealth (web + app intake → async MD review → owned compounding pharmacy → recurring ship). 4M subscribers, ~55% gross margin, accelerating personalization mix (multi-ingredient compounded SKUs lock in higher LTV than commodity finasteride/sildenafil).
GLP-1 leg added in 2025 via compounded semaglutide under the $LLY / $NVO shortage exemption, then transitioned toward branded supply + oral GLP-1 / liraglutide as the FDA shortage list cleared.
(1) subscription model with >85% gross retention and rising AOV as users stack categories; (2) weight-loss category opens a $10B+ TAM the legacy DTC men's/women's base could never reach; (3) owned pharmacy + 503B facility = structural cost advantage vs Ro / pure-marketplace peers; (4) brand + paid-acquisition flywheel already amortized - incremental subs come at lower CAC than 2023; (5) optionality on a personalized longevity / hormone bundle adjacent to peptide and TRT demand.
(1) compounded GLP-1 revenue is regulator-dependent - every FDA shortage update (semaglutide cleared Q1 2025) is a step-function risk to the highest-growth SKU; (2) $LLY and $NVO are actively building DTC channels ($LLY Direct) that disintermediate the compounded route; (3) gross margin compression as branded GLP-1 supply replaces in-house compounded; (4) heavy reliance on paid social CAC - TikTok / Meta cost inflation directly hits unit economics; (5) async-prescribing model faces ongoing state medical-board and DEA scrutiny on stimulants, GLP-1s, and controlled substances.
Each weekday: the scan's ENTER setups with entry, stop and target, every new ticker teardown, and the bubble shifts that move names like this one. Free. Education, not advice.
No spam. One email per day max. Pro adds Telegram trade alerts and higher AI-assistant limits.
No major news in the last 7 days for HIMS - only listicles and opinion pieces, which we filter out by default. See everything anyway.
Auto-computed retracement of the trailing 52w low-high leg. Recomputed on each refresh; not a curated level.
Auto-computed retracement of the trailing 52w low-high leg. Recomputed on each refresh; not a curated level.
Auto-computed retracement of the trailing 52w low-high leg. Recomputed on each refresh; not a curated level.